Guardion Health Sciences Inc. (NASDAQ: (GHSI) stock gained by 12.38% at the last close while the GHSI stock price rose by 23.73% in the after-hours trading session. Guardion Health Sciences is a corporation that specializes in clinical nutrition and testing. Healthcare providers, their patients, and consumers may achieve their health objectives with Guardion’s array of scientific, scientifically supported nutrition, medicinal foods, and diagnostic solutions.
GHSI stock’ Upcoming Conference
Guardion’s marketing and development efforts are backed by equally remarkable scientific and medical advising groups, which are led by experienced business leaders and physicians with decades of expertise.
Chief Executive Officer Bret Scholtes of Guardion Health Sciences will deliver a company overview at the Benzinga Global Small-Cap Conference, which will be conducted online on October 27–28, 2021. Mr. Scholtes will give his company presentation at 1:15 p.m. ET on Wednesday, October 27.
Recent Past Development
Guardion Health Sciences today announced two significant projects aimed at improving customer quality of experience while also lowering expenses across the organization.
Guardion has agreed to end its lease on its corporate office and major warehouse location in San Diego, California, which was principally used for the Company’s ocular products business. This arrangement will go into effect at the end of October, and it is likely to save Guardion money in the long run. Guardion is in the process of transferring its product inventory to a third-party logistics company. Furthermore, in order to improve communication with its shareholders, customers, and other stakeholders, the Company has created a new and updated business and investor website.
The company’s Chief Executive Officer Bret Scholtes said,
They continue to assess their existing operations and how they can enhance customer service and sales, with a special emphasis on the recently bought Viactiv Company, all while carefully and responsibly regulating the cost structure to optimize shareholder value. They will continue their efforts to position Guardion as a prominent participant in the clinical nutrition market by solving these core challenges.
